(S046) Long-Term Outcome and Toxicity of Stereotactic Ablative Body Radiotherapy (SABR) for Liver Metastases From Solid Tumors

International Journal of Radiation Oncology, Biology, Physics, Volume 98, Issue 2, Supplement, 2017 Jun 1 | Lu, Yi, MD, PhD; Tang, Chad, MD, MS; Liao, Zhongxing, MD;...
Purpose To report toxicity and outcome after stereotactic ablative body radiotherapy (SABRacrnm1) for patients with liver metastases. Methods and Materials From 2005 to 2016, 127 patients with liver metastases from different primaries had been irr...

http://ift.tt/2qHVs6o